Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers.

J Transl Med · 2012 · PMC3478973 · PMID 22873289

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

The combination of P276-00 and gemcitabine showed highly significant apoptosis of 25.4% and 73% at 96 h and 120 h respectively as compared to either drug alone ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.